Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001493152-20-005646)

Filing Details

Accession Number:
0001493152-20-005646
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2020-04-01 21:24:57
Reporting Period:
2020-03-30
Accepted Time:
2020-04-01 21:24:57
Original Submission Date:
2020-04-01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1642380 Oncocyte Corp OCX () 4/A
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1299153 Asbury Ronald Andrews 15 Cushing
Irvine CA 92618		 Ceo And President Yes Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, No Par Value Acquisiton 2020-03-30 27,216 $2.26 44,698 No 4 P Direct
Common Stock, No Par Value Acquisiton 2020-03-31 18,000 $2.37 62,698 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. Amendment to correct March 31, 2020 share purchase price by replacing erroneous comma with a decimal point.